Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA.... by Emir Matpan (21655811)

“…Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. …”

MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.... by Indrani Bera (804948)

Average % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01,... by Indrani Bera (804948)

Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.... by Indrani Bera (804948)

Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx by Livia De Picker (8319105)

“…</p><p>Conclusion: The acute psychotic state is marked by state-specific increases of immune markers and decreases in peripheral IDO pathway markers. …”

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Subjects:

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Results for the time from infection to hospitalisation, segmented by symptom onset date. by Thomas Ward (688068)

Subjects:

Category B results and lognormal.stan program listing. by Thomas Ward (688068)

Subjects:

Results for the time from infection to hospitalisation by sex and age. by Thomas Ward (688068)

Subjects:

Results for the time from infection to death, segmented by symptom onset date. by Thomas Ward (688068)

Subjects:

Events O, A and B for the three time delay quantities. by Thomas Ward (688068)

Subjects:

Violin plots of the best fit modelled distributions of times to clinical outcome over the course of the pandemic for category A. by Thomas Ward (688068)

Subjects:

Results for the time from infection to death by sex and age. by Thomas Ward (688068)

Subjects:

Results for the time from hospitalisation to death by sex and age. by Thomas Ward (688068)

Subjects:

Results for the time from hospitalisation to death, segmented by hospitalisation date. by Thomas Ward (688068)

Subjects:

Bar charts of the times to clinical outcome by age and sex, with standard errors. by Thomas Ward (688068)

Subjects:

Line graph of the relationship between healthcare pressure, as measured by daily hospital admissions, and the mean modelled clinical time delays. by Thomas Ward (688068)

Subjects:

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)